"We demonstrated that using artificial intelligence (AI) analysis of ultrasound images to rule out thyroid cancer and avoid biopsy is definitely possible," Dr. Nikita Pozdeyev of the University of Colorado Anschutz Medical Campus, in Aurora, said in a news release.
"This technology could assist radiologists and endocrinologists in choosing which thyroid nodules should undergo biopsy, especially those in the community who may not review a large number of thyroid ultrasound images," he added.
The researchers trained their AI model on more than 30,000 ultrasound images of 621 thyroid nodules to classify the nodules as "cancer" or "no cancer" and externally validated the results on a different set of ultrasound images of 145 nodules.
The deep learning classifier achieved a negative predictor value (true negative) of 94% to 99% - comparable to that of the benign fine-needle aspiration biopsy with "acceptable" specificity of 52% to 61%, Dr. Pozdeyev reported.
Microcalcifications and spongiform appearance were "reliably" recognized by the AI algorithm as malignant and benign features, respectively, he noted.
Dr. Pozdeyev noted that thyroid nodules are very common and fine-needle aspiration biopsy is used to diagnose thyroid cancer. However, most biopsies show benign (noncancerous) results. If confirmed in other studies, use of this AI tool could help patients avoid unnecessary biopsy for thyroid nodules.
SOURCE: https://endo2022.endocrine.org/ Endocrine Society Annual Meeting (ENDO 2022), June 13, 2022.
By Megan Brooks
Posted on
Previous Article
« Roche’s study flop marks yet another Alzheimer’s setback Next Article
Focused ultrasound controls prostate cancer with fewer side effects »
« Roche’s study flop marks yet another Alzheimer’s setback Next Article
Focused ultrasound controls prostate cancer with fewer side effects »
Related Articles
February 11, 2022
Online tool helps ovarian-cancer patients manage symptoms
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com